DMRA · Damora Therapeutics, Inc.
$29.99
-3.00 (-9.09%)
At close · Jul 22
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$1.85B
Shares
61.55M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-22 | Firmani Lori | Officer | 7,615 | 2026-06-22 | Maxim Group |
| 2023-10-02 | OrbiMed Israel Partners II, L.P. | Shareholder | 244,527 | 2023-10-02 | Merrill Lynch, Pierce, Fenner & Smith Incorporated |
| 2023-10-02 | OrbiMed Private Investments VII, LP | Shareholder | 585,274 | 2023-10-02 | Merrill Lynch, Pierce, Fenner & Smith Incorporated |
| 2023-10-02 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 37,675 | 2023-10-02 | Merrill Lynch, Pierce, Fenner & Smith Incorporated |
| 2023-10-02 | The Biotech Growth Trust PLC | Shareholder | 57,312 | 2023-10-02 | Merrill Lynch, Pierce, Fenner & Smith Incorporated |
| 2023-08-30 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 78,659 | 2023-08-30 | Bank of America |
| 2023-08-30 | OrbiMed Private Investments VII, LP | Shareholder | 1,222,125 | 2023-08-30 | Bank of America |
| 2023-08-30 | OrbiMed Israel Partners II, L.P. | Shareholder | 510,610 | 2023-08-30 | Bank of America |
| 2023-08-30 | The Biotech Growth Trust PLC | Shareholder | 119,679 | 2023-08-30 | Bank of America |
| 2023-08-21 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 75,473 | 2023-08-15 | Bank of America |
| 2023-08-21 | OrbiMed Israel Partners II, L.P. | Shareholder | 631,048 | 2023-08-21 | Bank of America |
| 2023-08-21 | The Biotech Growth Trust PLC | Shareholder | 147,910 | 2023-08-21 | Bank of America |
| 2023-08-21 | OrbiMed Private Investments VII, LP | Shareholder | 1,510,375 | 2023-08-21 | Bank of America |
| 2023-08-15 | OrbiMed Private Investments VII, LP | Shareholder | 1,172,714 | 2023-08-15 | Bank of America |
| 2023-08-15 | The Biotech Growth Trust PLC | Shareholder | 114,843 | 2023-08-15 | Bank of America |
| 2023-08-15 | OrbiMed Israel Partners II, L.P. | Shareholder | 489,970 | 2023-08-15 | Bank of America |
| 2023-08-15 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 75,473 | 2023-08-15 | Bank of America |
| 2023-07-31 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 162,153 | 2023-07-31 | Bank of America |
| 2023-07-31 | OrbiMed Private Investments VII, LP | Shareholder | 930,717 | 2023-07-31 | Bank of America |
| 2023-07-31 | The Biotech Growth Trust PLC | Shareholder | 246,830 | 2023-07-31 | Bank of America |
| 2023-07-31 | OrbiMed Israel Partners II, L.P. | Shareholder | 180,300 | 2023-07-31 | Bank of America |
| 2023-07-25 | The Biotech Growth Trust PLC | Shareholder | 8,100 | 2023-07-25 | Bank of America |
| 2023-07-25 | OrbiMed Israel Partners II, L.P. | Shareholder | 4,700 | 2023-07-25 | Bank of America |
| 2023-07-25 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 7,800 | 2023-07-25 | Bank of America |
| 2023-07-25 | OrbiMed Private Investments VII, LP | Shareholder | 26,700 | 2023-07-25 | Bank of America |
| 2023-07-13 | OrbiMed Private Investments VII, LP | Shareholder | 132,100 | 2023-07-13 | Bank of America |
| 2023-07-13 | The Biotech Growth Trust PLC | Shareholder | 14,700 | 2023-07-13 | Bank of America |
| 2023-07-13 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 9,800 | 2023-07-13 | Bank of America |
| 2023-07-13 | OrbiMed Israel Partners II, L.P. | Shareholder | 52,800 | 2023-07-13 | Bank of America |
| 2023-04-10 | OrbiMed Israel Partners II, L.P. | Shareholder | 9,064 | 2023-04-10 | Themis Trading LLC |
| 2023-04-10 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 1,686 | 2023-04-10 | Themis Trading LLC |
| 2023-04-10 | The Biotech Growth Trust PLC | Shareholder | 2,512 | 2023-04-10 | Themis Trading LLC |
| 2023-04-10 | OrbiMed Private Investments VII, LP | Shareholder | 22,638 | 2023-04-10 | Themis Trading LLC |
| 2023-04-05 | OrbiMed Private Investments VII, LP | Shareholder | 109,532 | 2023-04-05 | Themis Trading LLC |
| 2023-04-05 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 8,143 | 2023-04-05 | Themis Trading LLC |
| 2023-04-05 | OrbiMed Israel Partners II, L.P. | Shareholder | 43,810 | 2023-04-05 | Themis Trading LLC |
| 2023-04-05 | The Biotech Growth Trust PLC | Shareholder | 12,215 | 2023-04-05 | Themis Trading LLC |
Showing 1–37 of 37 filings